Zdrowie i gospodarka · 20/10/2022

FDA Extends Comment Period for Animal Generic Drug User Fee Act Reauthorization

The Food and Drug Administration is extending the comment period for the reauthorization of the Animal Generic Drug User Fee Act (AGDUFA IV) until November 30, 2022, due to a delay in posting the Performance Goals and Procedures Letter.